Wednesday, July 29, 2020
This article from Marijuana Moment, headlined, "Nearly Seven-In-Ten New Jersey Voters Support Marijuana Legalization Ballot Measure, Poll Finds," reports on a notable new poll suggesting that many members of the the Garden State are eager to vote to legalize marijuana. Here are the details:
A supermajority of New Jersey voters say in a new poll that they support a marijuana legalization referendum that will appear on the November ballot. The survey, which was conducted by DKC Analytics and released on Tuesday, shows that 68 percent of respondents back the policy change. That’s a seven percentage point increase compared to a separate poll on the issue released in April.
The survey also shows that voters support allowing social consumption lounges for cannabis, 50 percent to 38 percent. Most respondents (56 percent) agreed that online ordering and home delivery for marijuana products would be a “good way to provide adults with access.”
Supporters of the legalization initiative were asked to select the reasons they hold that position. Seventy percent said they feel a regulated system will curb the illicit market, 61 percent said it would generate tax revenue, 61 percent said regulations would ensure safer products, 60 percent said ending criminalization would save taxpayer dollars that would otherwise go to law enforcement, 57 percent said legalization would stimulate the economy and create jobs and 43 percent said cannabis is safer than alcohol....
Another supermajority (68 percent) said people with prior low-level cannabis convictions should be able to have their records expunged. The same percentage of respondents said that marijuana tax revenue should go toward drug education and awareness programs.
“The polling results confirmed our belief that there is overwhelming support for the creation of a regulated, adult-use cannabis marketplace in New Jersey,” John Fanburg, an attorney at Brach Eichler, which commissioned the survey, said in a press release. “Respondents supported it because it will create tremendous opportunity. It will create vitally needed new businesses, the state will receive significant tax revenues and illegal sales will be dramatically reduced, if not eliminated. Voters see this as a win for everyone.”
As has historically been the case, people who identified as Democrats are more likely to support legalization (78 percent), but majorities of Republicans (57 percent) and independents (63 percent) also favor the policy change.
Another interesting finding was that most people who participated in the survey (57 percent) said they do not personally consume cannabis. The poll involved phone interviews with 500 New Jersey likely voters from July 7-12. ”The strong level of support for correcting this decades-old inequality, especially in the context of recent protests of inherent bias in law enforcement, should be well noted by our legislators who will be tasked with correcting this unfortunate consequence of the failed policy of prohibition,” Charles Gormally of Brach Eichler said.
Thursday, July 23, 2020
The title of this post is the title of this new research from multiple authors published this month in the American Journal of Preventive Medicine. Here is its abstract:
Rates of adolescent substance use have decreased in recent years. Knowing whether nonmedical marijuana legalization for adults is linked to increases or slows desirable decreases in marijuana and other drug use or pro-marijuana attitudes among teens is of critical interest to inform policy and promote public health. This study tests whether nonmedical marijuana legalization predicts a higher likelihood of teen marijuana, alcohol, or cigarette use or lower perceived harm from marijuana use in a longitudinal sample of youth aged 10–20 years.
Data were drawn from the Seattle Social Development Project–The Intergenerational Project, an accelerated longitudinal study of youth followed both before (2002–2011) and after nonmedical marijuana legalization (2015–2018). Analyses included 281 youth surveyed up to 10 times and living in a state with nonmedical marijuana legalization between 2015 and 2018 (51% female; 33% white, 17% African American, 10% Asian/Pacific Islander, and 40% mixed race or other).
Multilevel modeling in 2019 showed that nonmedical marijuana legalization predicted a higher likelihood of self-reported past-year marijuana (AOR=6.85, p=0.001) and alcohol use (AOR 3.38, p=0.034) among youth when controlling birth cohort, sex, race, and parent education. Nonmedical marijuana legalization was not significantly related to past-year cigarette use (AOR=2.43, p=0.279) or low perceived harm from marijuana use (AOR=1.50, p=0.236) across youth aged 10–20 years.
It is important to consider recent broad declines in youth substance use when evaluating the impact of nonmedical marijuana legalization. States that legalize nonmedical marijuana for adults should increase resources for the prevention of underage marijuana and alcohol use.
Tuesday, July 14, 2020
"The Spillover Effect of Recreational Marijuana Legalization on Crime: Evidence From Neighboring States of Colorado and Washington State"
The title of this post is the title of this new research paper published in the Journal of Drug Issues and authored by Guangzhen Wu, Francis D. Boateng and Xiaodong Lang. Here is its abstract:
An ongoing debate exists about the implications of recreational marijuana legalization to public safety. One important public concern is how recreational marijuana legalization may affect crime in neighboring states that have not legalized. Based on Uniform Crime Report (UCR) data from 2003 to 2017, this study used difference-in-differences (DID) analysis to examine the potential spillover effect of recreational marijuana legalization in Colorado and Washington State, with a special focus on the examination of the changes in the rates of a variety of crimes in the border counties of neighboring states relative to the nonborder counties in these states following Colorado’s and Washington’s legalization.
Results provide some evidence suggesting a spillover crime reduction effect of legalization, as reflected by the significant decreases in the rates of property crime, larceny, and simple assault in the Colorado region that includes six neighboring states. Results also suggest that the effects of marijuana legalization on crime in neighboring states vary based on crime type and state.
Monday, July 13, 2020
The Dayton Daily News has this interesting new piece on Ohio's medical marijuana program under the headline "$133M of medical pot sold in 1st year as pandemic legitimized industry." Here are excerpts:
The coronavirus pandemic has wreaked havoc on the state’s economy, but those in the medical marijuana industry say the virus legitimized the fledgling program in Ohio. The medical marijuana program, which is run by the Ohio Board of Pharmacy and the Commerce Department, was fully functional in April 2019. Sales have significantly increased over the past year.
In May of last year, about $2.2 million and about 300 pounds of medical marijuana product was sold in the state of product has been sold, according to data from the Ohio Department of Commerce. Medical marijuana sales in Ohio then jumped from $7.7 million this past February to $12.9 million in March — more than 1,500 pounds, according to the Ohio Department of Commerce. About $10.9 million of medical marijuana product was sold in April.
As of June 14, the most recent data available, a total of $133.9 million and 16,225 pounds of medical marijuana product has been sold since the program started.
The state has collected about $3.8 million in sales tax on the medical marijuana program from July 2019 to March 2020, according to the Ohio Department of Taxation. The state of Ohio’s fiscal year runs from July 1 to June 30.Permissive sales tax collected statewide in that time was $942,673, the Department of Taxation said. Permissive sales tax is collected by local entities, like the county and regional transit authority. The state wouldn’t release county-by-county sales tax data. Larry Pegram is the president of Pure Ohio Wellness.... Dispensaries were deemed essential during the statewide coronavirus shut down issued in March and lasting through May. That was huge for the medical marijuana industry, Pegram said.“That legitimized the whole program,” Pegram said. “This has become more acceptable, people are now seeing it more as an alternative medicine. ”Medical marijuana sales have increased every month the dispensaries have been open, Pegram said. There are now 51 dispensaries operating in Ohio. Six more dispensaries have provisional licenses and are working toward opening in the state.
When the pandemic first started, Pegram said people rushed to get product. But when dispensaries were deemed essential, sales settled down a bit. “It was scary at first, I think for everyone,” Pegram said. “But we realized we needed to stay open for our patients. For some of them, we are their lifeline.”...
More than 109,000 Ohioans are registered medical marijuana patients as of May 31, the most recent data available. In May of last year, 35,162 Ohioans were registered patients. About 7% of those patients are veterans. More than 600 of Ohio’s medical marijuana patients have been diagnosed with a terminal illness. Many Pure Ohio Wellness patients are seniors who use medical marijuana for pain management, Pegram said.
Licensed dispensaries reported about 81,200 unique patients who purchased medical marijuana as of May 31, according to the Ohio Automated Rx Reporting System. In May 2019, about 20,000 unique patients purchased medical marijuana.Ohioans can get a doctor’s order to use medical marijuana if they have one of the qualifying conditions, including chronic pain, Alzheimer’s, cancer, epilepsy, fibromyalgia or HIV/AIDS.Gould said he believes the Ohio Medical Board should add anxiety, autism and opioid withdrawl to the approved list of conditions.
Saturday, July 11, 2020
The question in the title of this post is the title of this new commentary at The Nation authored by John Nichols. The piece is in the same vein as the one noted here asking why Joe Biden won't embrace legalization. Here are excerpts:
Some political issues are hard to wrestle with. Some are easy. Legalizing marijuana is easy.
A Pew Research Center survey found last fall that Americans back legalization by a 67-32 margin. The numbers spike among Democrats, 78 percent of whom favor ending this form of prohibition. But there’s also majority support — 55 percent — among Republicans. Among voters under age 30, support for legalization is sky-high.
Enthusiasm for legalization extends far beyond the large number of Americans who are recreational users of marijuana to include millions of people who recognize, as does the American Civil Liberties Union, that “Marijuana Legalization Is a Racial Justice Issue.”...
When the [Democratic] party’s task force on criminal justice reform released its policy recommendations this week, legalization was off the agenda. That was just one example of the caution that permeates the 110-page document submitted to the Democratic National Committee’s platform drafters by the six task forces that were set up in May by presumptive Democratic presidential nominee Joe Biden and his chief rival for the party’s nomination, Vermont Senator Bernie Sanders....
There’s criticism of mass incarceration and a good proposal to restrict federal funding for states that maintain cash bail systems. But there’s no plan to abolish the scandal-plagued Immigration and Customs Enforcement agency or to defund the police with an eye toward establishing new law enforcement models that strive for public safety and justice....
Color of Change senior director of criminal justice campaigns Scott Roberts told Politico that Biden “still seems to embrace kind of a law-and-order lite.” That was certainly the case when it came to upending marijuana laws.
The commission rejected legalization — the popular position backed by Sanders. Instead, it stuck to the more cautious approach that’s been maintained by Biden, a supporter of the drug war during his own Senate years who has softened some but not all of his old positions. Instead of legalization, the commission proposed to “decriminalize marijuana use,” reschedule cannabis on the Controlled Substances Act (CSA), and leave it to the states to decide about legalization.
The National Organization for the Reform of Marijuana Laws concluded that the proposal “is out of step with public opinion [and] would do little to mitigate the failed policy of federal prohibition.”
“It is impractical at best and disingenuous at worst for the Biden campaign to move ahead with these policy proposals. Rescheduling of marijuana under the Controlled Substances Act would continue to make the federal government the primary dictators of cannabis policy, and would do little if anything to address its criminal status under federal law,” explained Erik Altieri, the executive director of the National Organization for the Reform of Marijuana Law. “Rescheduling marijuana is intellectually dishonest. Just as cannabis does not meet the strict criteria of a Schedule I controlled substance, it similarly does not meet the specific criteria that define substances categorized in schedules II through V.”
Why didn’t the commission simply endorse the Marijuana Justice Act, which has been introduced by New Jersey Democrat Cory Booker in the Senate and House Democrats Barbara Lee and Ro Khanna? Sanders supports the measure, as do two of Biden’s vice presidential prospects, Warren and Senator Kamala Harris. The answer is that Biden has a long history of opposing legalization — going so far in his resistance to the idea that, last year, Representative Alexandria Ocasio-Cortez suggested that the former vice president was employing “Reagan-era talking points.”
Prior related post:
July 11, 2020 in Campaigns, elections and public officials concerning reforms, Federal Marijuana Laws, Policies and Practices, Polling data and results, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Wednesday, July 8, 2020
The title of this post is the title of this notable new paper in the journal Contemporary Drug Problems authored by Lindsey Beltz, Clayton Mosher and Jennifer Schwartz. Here is its abstract:
Cannabis is traversing an extraordinary journey from an illicit substance to a legal one, due in part to an unprecedented wave of bottom-up law reform through successful citizen ballot initiatives. Yet, even in states that have legalized recreational cannabis, there is substantial geographic variability in support of cannabis legalization. Geographic variability in voter support for cannabis legalization is impactful (e.g., county moratoriums/bans) yet poorly understood.
This paper demonstrates the consequences of county-level population demographics, sociopolitical factors, and community differences in experience with criminalization of cannabis possession for understanding county-level variation in support of recreational cannabis law reform on (un)successful ballot measures in California (2010), Colorado (2012), Washington (2012), and Oregon (2014).
OLS regression analyses of nearly 200 counties indicate that differences in racial and ethnic composition (% Black, Hispanic), political affiliation (% Republican), past criminalization, gender composition, and higher education level of residents all predict county-level variation in support for liberalization of cannabis law. Stronger Republican political leanings and/or higher percentages of Black or Hispanic residents were associated with reduced support, whereas higher education, male sex composition, and greater past criminalization were associated with increased support for cannabis legalization across counties. Religiosity and rurality were inconsequential as predictors of county-level voting patterns favoring recreational cannabis. The substantial geographic variability in voter support for cannabis legalization has significant implications for policy implementation and effectiveness.
Tuesday, July 7, 2020
The title of this post is the title of this significant new digital book put together by Chris Nani now available via SSRN. I am proud to be able to say Chris is a former student who has been doing amazing work in the cannabis space since his time in law school (including the development of a great tool for judging social equity programs available as "Social Equity Assessment Tool for the Cannabis Industry"). In his new book, Chris has assembled short and effective essays from more than a dozen experts; here is the book's SSRN abstract:
Understanding Social Equity is a compilation of viewpoints from various authors with diverse backgrounds. From attorneys, policy analysts, and journalists to advocates, business owners, and social equity applicants, my goal was to provide as many perspectives as possible – some of which may conflict with other authors to provide regulators a wide range of respected opinions about social equity programs. Together, we believe this compilation can be used as a guide for drafters and regulators when determining minute details about how they would like to create or improve their social equity program.
The goal of this book can further be defined into four objectives:
● Educate regulators on what social equity programs are and their importance.
● Why certain criteria should be used to define social equity applicant eligibility.
● An analysis of prior social equity programs.
● Key factors for social equity programs.
I was quite honored that Chris asked me to author an essay for this book. My contribution is titled simply "Tracking Social Equity," and here is how it begins:
Chris Nani, in the first sentence of his preface to this volume, defines social equity programs as those that “seek to remediate and help individuals, families, and communities harmed by the War on Drugs.” Behind this crisp definition of social equity programs stands a series of complicated questions about just who should be the focal point for remediation and help and how these programs should be oriented and assessed. By starting to unpack these questions, we can begin to appreciate just why these programs are so important in principle and so challenging in practice.
July 7, 2020 in Business laws and regulatory issues, Criminal justice developments and reforms, History of Marijuana Laws in the United States, Race, Gender and Class Issues, Recreational Marijuana Commentary and Debate | Permalink | Comments (0)
Monday, July 6, 2020
The question in the title of this post is drawn from the headline of this great new Atlantic piece by Edward-Isaac Dovere fully titled "The Marijuana Superweapon Biden Refuses to Use: Legalizing marijuana is extremely popular. So why won’t Joe Biden embrace the idea?". Here are extended excerpts from an interesting piece worth reading in full:
Democratic political consultants dream of issues like marijuana legalization. Democrats are overwhelmingly in favor of it, polls show. So are independents. A majority of Republicans favor it now too. It motivates progressives, young people, and Black Americans to vote. Put it on the ballot, and it’s proved a sure way to boost turnout for supportive politicians. It’s popular in key presidential-election states, including Michigan, Pennsylvania, Colorado, Florida, Arizona, and Virginia. There’s no clear political downside — although marijuana legalization motivates its supporters, it doesn’t motivate its opponents. For the Democratic presidential nominee, the upsides of supporting it would include energizing a very committed group of single-issue voters and making a major move toward criminal-justice reform and the Bernie Sanders agenda.
Joe Biden won’t inhale.
Democrats eager for Biden to support legalization have theories about why he won’t. His aides insist they’re all wrong. It’s not, they say, because he’s from a generation scared by Reefer Madness. It’s not, they say, because he spent a career in Washington pushing for mandatory minimum sentencing and other changes to drug laws. It’s definitely not, according to people who have discussed the policy with him, because he’s a teetotaler whose father battled alcoholism and whose son has fought addiction, and who’s had gateway-drug anxieties drilled into him. With legalization seeming such an obvious political win, all that’s stopping Biden, current and former aides say, is public health. He’s read the studies, or at least, summaries of the studies (campaign aides pointed me to this one). He wants to see more. He’s looking for something definitive to assure him that legalizing won’t lead to serious mental or physical problems, in teens or adults....
If Biden really has his eyes on public health, he should think about how many Black people end up in jail for marijuana sale and possession, argues Jackson, Mississippi, Mayor Chokwe Lumumba — a young Black progressive who oversaw local decriminalization in his city in 2018.... Alternatively, John Fetterman, the lieutenant governor of Pennsylvania, says Biden should think about how legalization could raise tax revenue in the post-pandemic economy of state budget deficits....
Amid the criticism that Biden hasn’t taken a definitive stance on legalization, it’s easy to lose track of how far ahead he is of any other major-party presidential nominee in history in terms of changing marijuana policy. He’d decriminalize use, which would mean fines instead of jail time, and move to expunge records for using. He’d remove federal enforcement in states that have legalized the drug. That’s further, by far, than Donald Trump, or Barack Obama, has gone. Biden would move marijuana off as a Schedule 1 narcotic, the same category as heroin, but would not take it off the illegal-drugs schedule entirely, so that federal law would treat it the way it does alcohol or nicotine....
“As science ends up with more conclusive evidence regarding the impact of marijuana, I think he would look at that data. But he’s being asked to make a decision right now. This is where the science guides him,” Stef Feldman, Biden’s policy director, explained to me.... There isn’t some conclusive study about health effects that Biden is ignoring, but one is also not likely to emerge anytime soon. And though they insist this is all about health, other ripples from legalization are on the minds of institutionalists like Biden and his close advisers: trade deals that require both sides to keep marijuana illegal would have to be rewritten, half a century of American pressure on other countries about their drug policies would be reversed, and hard-line police unions would have to be convinced that he wasn’t just giving in to stoners.
Realistically, marijuana isn’t a priority right now for the campaign. Legalization is at once too small an issue for Biden’s tiny team to focus on and too large an issue to take a stand on without fuller vetting. And it comes with a frustration among people close to Biden, who point out that liberals talk about trusting science on everything from climate change to wearing masks — and, notably, wanted vaping restricted because the health effects were unclear — but are willing to let that standard slide here because they want marijuana to be legal.
Biden’s compromise: going right to the edge of legalization, while appointing a criminal-justice task force for his campaign whose members have each supported at least some approach to legalization. But that sort of signaling doesn’t get people to the polls. “Being cute is fine. Being bold is motivating,” Ben Wessel, the director of NextGen America, a group focused on boosting political involvement among younger voters, told me.
“If Biden said he wants to legalize marijuana tomorrow, it would help him get reluctant young voters off the fence and come home to vote for Biden — especially Bernie [Sanders] supporters, especially young people of color who have been screwed by a criminal-justice system that treats them unfairly on marijuana issues,” Wessel told me. Publicly supporting marijuana legalization would be an easy, attention-grabbing move, and might help many Sanders diehards get past the fact that he’s not where they want him to be on the rest of their candidate’s democratic-socialist agenda.
In 2018, top Democrats credited a legalization ballot initiative in Michigan with boosting turnout and producing the biggest blue wave in the country — winning races for governor, Senate, attorney general, and secretary of state, along with flipping two congressional seats and multiple state-legislature seats. A ballot initiative is expected for the fall in Arizona, New Jersey, South Dakota, and possibly Montana. Anyone who believes — hopefully, or out of cynical political calculation — that Biden will announce some big change in his thinking, aides told me, will be disappointed.
I really like lots of aspects of this commentary, and I generally believe support for marijuana reform is a sound and significant political strategy these days. But, as this piece highlights, when Biden's opponent is Donald Trump, it will still be easy for Biden to claim to be the most reform-minded candidate. And while support for full legalization might attract younger voters, it also will attract hard questions about whether Biden would support legalizing other drugs. By saying he will follow the research and the science, Biden can appear both wise and flexible on an issue that can still generate more heat than light.
Moreover, I think the political calculations can be a bit more nuanced here if one thinks about swing states and swing voters. A number of potential swing states, ranging from Georgia and North Carolina to Iowa and Ohio and Wisconsin (and Texas?), are not states with a track record of significant voter support for full marijuana legalization. Perhaps even more importantly, key voting blocks like suburban women and older white men are the populations that have generally been most resistant to marijuana reforms. Though I still think support for major marijuana reforms would be a political plus for Biden, I do not think it is obviously a "superweapon" being left on the sidelines.
July 6, 2020 in Campaigns, elections and public officials concerning reforms, Federal Marijuana Laws, Policies and Practices, History of Marijuana Laws in the United States, Political perspective on reforms, Recreational Marijuana Commentary and Debate, Who decides | Permalink | Comments (0)
Saturday, July 4, 2020
Kyle Jaeger has this helpful and timely piece at Marijuana Moment discussing the state of direct democracy marijuana and drug reform campaigns in the states. The piece is headlined "As Signature Deadlines Approach, Here’s Where Marijuana And Drug Policy Reform Campaigns Stand," and is worth a full read. Here are highlights:
Several drug policy reform campaigns are in the final stretch as deadlines to submit signatures for proposed ballot initiatives loom this week and next.
While the coronavirus pandemic dealt serious blows to marijuana, psychedelics and other drug reform groups in jurisdictions across the country, forcing some to end their campaigns, activists in Arizona, Idaho, Nebraska, Oregon and Washington, D.C. are still in the game, with some running against the clock to turn in enough valid signatures to qualify and others now waiting for officials to validate petitions they’ve already submitted. That’s in addition to measures that have already qualified for November ballots in states like Mississippi, New Jersey and South Dakota.
The proposed ballot measures would accomplish everything from legalizing cannabis to decriminalizing psychedelics such as psilocybin and ayahuasca. Here’s a status update on where they stand:
Arizona Deadline: July 2
Smart & Safe Arizona is a campaign to put marijuana legalization on the November ballot, and it seems to be in good shape to qualify....
Idaho Deadline: TBD
While the original deadline to submit signatures for an initiative to legalize medical marijuana passed on May 1, a federal judge recently ruled that the state must make accommodations for a separate non-cannabis ballot campaign due to signature gathering complications caused by the coronavirus pandemic and the government’s response to it. Activists feel the ruling will also apply to the marijuana measure....
Nebraska Deadline: July 3
Activists behind an initiative to legalize medical cannabis in the state turned in 182,000 raw signatures on Thursday — well more than the 121,669 valid submissions needed to qualify for the ballot....
Oregon Deadline: July 2
A campaign to legalize psilocybin mushrooms for therapeutic purposes already submitted signatures that they feel will qualify them for the ballot....
Washington, D.C. Deadline: July 6
Washington, D.C. activists are continuing to collect signatures for a proposed measure to make enforcement of laws against various entheogenic substances such as psilocybin, ayahuasca and ibogaine among the city’s lowest law enforcement priorities....
Here’s the status of other drug policy campaigns that have either succeeded or failed so far this year:
The Oregon Secretary of State’s office announced on Tuesday that a campaign to decriminalize currently illicit drugs and expand substance misuse treatment has qualified for the ballot.
Prior to the COVID-19 outbreak and stay-at-home mandates, measures to legalize marijuana for medical and recreational purposes qualified for South Dakota’s November ballot.
Mississippi activists gathered enough signatures to qualify a medical cannabis legalization initiative for the ballot—though lawmakers also approved a competing (and from advocates’ standpoint, less desirable) medical marijuana proposal that will appear alongside the campaign-backed initiative.
The New Jersey legislature approved putting a cannabis legalization referendum before voters as well.
Montana activists recently turned in more than 130,000 signatures to qualify a pair of marijuana initiatives—one to legalize the plant for adult use and another stipulating that individuals must be 21 or older to participate — for the November ballot. The state is currently validating those submissions.
A campaign to legalize marijuana in Arkansas will not qualify for the ballot this year, a spokesperson told Marijuana Moment on Tuesday.
Activists behind an initiative to decriminalize currently illicit drugs and expand access to treatment services in Washington State said last week that they will no longer be pursuing the ballot due to the coronavirus pandemic. Instead, they are seeking to enact the policy change through the legislature during the next session starting January 2021.
An effort to place a psilocybin legalization measure on California’s ballot ended after the coronavirus pandemic presented petitioning difficulties and officials didn’t agree to a request to allow electronic signature gathering.
A campaign to legalize cannabis in Missouri officially gave up its effort for 2020 due to signature collection being virtually impossible in the face of social distancing measures.
North Dakota activists ended their push to place a marijuana legalization measure on the 2020 ballot and will instead seek qualification for 2022.
July 4, 2020 in Campaigns, elections and public officials concerning reforms, Initiative reforms in states, Medical Marijuana State Laws and Reforms, Recreational Marijuana State Laws and Reforms, Who decides | Permalink | Comments (0)
Friday, July 3, 2020
Is it growing clearer that marijuana reform is criminal justice reform and racial justice imperative?
The question in the title of this post is prompted by this new Crime Report piece headlined "Marijuana Laws ‘Central’ to Justice Reform, Advocates Say." Here is how it starts:
As protests against racism continue to march on across the country, conversations have sparked a new dialogue about policing, criminal and racial justice, and even the War on Drugs.
Lawmakers and advocates alike say the latter of these dialogues must play “a central part,” seeing that the War on Drugs and policing of marijuana usage has disproportionately targeted Black Americans, and encouraged negative police interactions, Stateline and Brookings report.
In light of these discussions, some states are taking active roles in changing the current narrative.
I would also recommend these linked pieces from Stateline and Brookings:
- "Policing Protests Propel Marijuana Decriminalization Efforts"
- "Marijuana’s racist history shows the need for comprehensive drug reform"